ZBRA:NASDAQZebra Technologies Corporation Analysis

Zebra Technologies is trading well below its discounted cash flow implied fair value, suggesting a sizable upside potential. The 20‑day moving average sits above the 50‑day average, while the price remains under the 200‑day average, indicating a neutral to slightly bearish technical stance. Momentum indicators show a mid‑range RSI and a bearish MACD crossover, and the stock is hovering close to a key support level, with volatility and beta both notably higher than the market average. Recent headlines highlight new AI‑driven initiatives in healthcare and supply‑chain automation, as well as a solid Q4 earnings beat that reinforced the company's growth narrative.
Fundamentally, revenue is expanding at double‑digit rates and margins remain healthy, while cash flow generation comfortably covers operating needs. The balance sheet carries a moderate debt load with ample cash, but the firm does not pay a dividend, reflecting a focus on reinvestment. Compared with peers, the price‑to‑earnings multiple is lower than the industry average, positioning the stock as a growth‑oriented value play.